LOX expression and activity are increased in both animal models and patient samples of ALS [75,76], and LOX, LOXL2 and LOXL4 are elevated in the fibroblasts and serums of patients with systemic sclerosis [37,77,78,79,80,81] (Table 1). Here, LOX is linked to systemic sclerosis.